주식회사네오켄바이오 / NeoCannBio Co., Ltd.
NeoCannBio Co., Ltd.'s KOBDi Score is 59.28 as of Sep 2026, up 4.33 points since Apr 2025; it rose in 6 and fell in 4 of the 12 monthly updates. As of Sep 2026 it is ahead of about 77% of companies in its industry, against 76% in Aug 2026 and 56% in Apr 2025. Its strongest position was 77% (Sep 2026) and its weakest 53% (Aug 2025).
A year earlier, in Aug 2025, its score was 52.80 and it was ahead of about 53% of companies in its industry.
| Sep 2026 | 59.28 | ahead of 77% |
| Aug 2026 | 57.25 | ahead of 76% |
| Jul 2026 | 57.25 | ahead of 76% |
| Jun 2026 | 57.08 | ahead of 76% |
| May 2026 | 56.43 | ahead of 76% |
| Apr 2026 | 55.75 | ahead of 76% |
| Mar 2026 | 56.43 | ahead of 76% |
| Feb 2026 | 57.01 | ahead of 76% |
| Dec 2025 | 57.01 | ahead of 74% |
| Aug 2025 | 52.80 | ahead of 53% |
| Jul 2025 | 54.42 | ahead of 56% |
| May 2025 | 54.18 | ahead of 59% |
| Apr 2025 | 54.95 | ahead of 56% |
| # | ||||
|---|---|---|---|---|
| 루카스바이오(주) Lucas Bio Co., Ltd. | 20–29 | #22 | ||
| 주식회사 씨드모젠 CdmoGen Co.,Ltd. | 20–29 | #20 | ||
| 미생물실증지원센터 Microbiological Verification Support Center | 50–99 | #19 | ||
| 파라택시스 코리아(주) PARATAXIS KOREA, INC. | 10–19 | #23 | ||
| 주식회사 바이오브릭스 Biobricks Co., Ltd. | 10–19 | #24 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is NeoCannBio Co., Ltd. located?
NeoCannBio Co., Ltd. is registered at 서울특별시 성북구 화랑로14길, South Korea (postal code 02792).
What industry is NeoCannBio Co., Ltd. in?
NeoCannBio Co., Ltd. belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medicinal compounds and antibiotics.
How many employees does NeoCannBio Co., Ltd. have?
NeoCannBio Co., Ltd. has 20–29 employees.
What is NeoCannBio Co., Ltd.'s KOBDi Score?
59.28 as of September 2026, ahead of about 77% of companies in its industry.
Who are NeoCannBio Co., Ltd.'s competitors?
Similar companies include Lucas Bio, CdmoGen and Microbiological Verification Support Center.

